J&J to pay $230m to New York to settle opioid charges
The settlement facilitates the exclusion of J&J from a trial that is scheduled to start in Suffolk County…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Jun 21
The settlement facilitates the exclusion of J&J from a trial that is scheduled to start in Suffolk County…
25 Jun 21
The FDA authorisation allows emergency use of Actemra for the treatment of Covid-19 in hospitalised adult and paediatric…
25 Jun 21
Donanemab is an investigational antibody therapy that has shown positive results in treating Alzheimer's disease in clinical trials
24 Jun 21
The NMPA approval was based on positive results from a single-arm Phase 2 trial conducted in NSCLC patients…
23 Jun 21
The EC approval is based on the data from the Phase 2 SPRINT Stratum 1 trial, in which…
23 Jun 21
ViiV Healthcare will also obtain Halozyme’s recombinant human hyaluronidase PH20 enzyme (rHuPH20) for four specific HIV medicine targets
22 Jun 21
The EC authorisation is based on the EMPEROR-Reduced trial, which showed a significant reduction in the combined relative…
21 Jun 21
Starpharma claims that its Viraleze is the only nasal spray to show more than 99.9% antiviral activity against…
21 Jun 21
EC approved Aubagio as the first oral MS therapy for RRMS, based on data from the Phase 3…
18 Jun 21
Upon closing of the transaction, Aldevron will operate as an individual company and a brand operating within Danaher's…